000 01256 a2200325 4500
005 20250514184155.0
264 0 _c20040930
008 200409s 0 0 eng d
022 _a1363-1950
024 7 _a10.1097/00075197-200405000-00004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRoth, Stephen M
245 0 0 _aMyostatin: a therapeutic target for skeletal muscle wasting.
_h[electronic resource]
260 _bCurrent opinion in clinical nutrition and metabolic care
_cMay 2004
300 _a259-63 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal
_xadministration & dosage
650 0 4 _aGene Expression
650 0 4 _aHumans
650 0 4 _aMuscle, Skeletal
_xdrug effects
650 0 4 _aMuscular Diseases
_xdrug therapy
650 0 4 _aMyostatin
650 0 4 _aRegeneration
_xdrug effects
650 0 4 _aTranscription, Genetic
650 0 4 _aTransforming Growth Factor beta
_xgenetics
700 1 _aWalsh, Sean
773 0 _tCurrent opinion in clinical nutrition and metabolic care
_gvol. 7
_gno. 3
_gp. 259-63
856 4 0 _uhttps://doi.org/10.1097/00075197-200405000-00004
_zAvailable from publisher's website
999 _c14790798
_d14790798